Apogee Therapeutics

Apogee Therapeutics is a clinical-stage biotechnology company pioneering the development of differentiated biologics to target immunological and inflammatory conditions. We are driven by a mission to address the high unmet medical needs in patients living with diseases such as atopic dermatitis, chronic obstructive pulmonary disease (COPD), and asthma. Our commitment extends beyond just developing therapies; we aim to improve the quality of life for patients through innovative treatments.

At Apogee, we prioritize psychological safety within our team to foster an environment where creativity and open communication thrive. We believe that by harnessing diverse perspectives, we can devise the best solutions for the challenges faced by patients and caregivers in managing inflammatory and immune disorders. Our skilled team includes experienced clinical and commercial leaders, drug developers, scientists, and physicians who are united in the pursuit of excellence. We are relentless in our quest for better therapies that can make a meaningful difference in the lives of those suffering from these debilitating conditions.